| Names | |
|---|---|
| Preferred IUPAC name 5-Amino-6-(7-amino-6-methoxy-5,8-dioxo-5,8-dihydroquinolin-2-yl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpyridine-2-carboxylic acid | |
| Other names Rufocromomycin, nigrin, bruneomycin [1] | |
| Identifiers | |
3D model (JSmol) | |
| 599390 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.021.366 |
| EC Number |
|
| 1240693 | |
| KEGG | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C25H22N4O8 | |
| Molar mass | 506.471 g·mol−1 |
| Hazards | |
| GHS labelling: | |
| | |
| Danger | |
| H300 | |
| P264, P270, P301+P316, P321, P330, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Streptonigrin is an aminoquinone antitumor and antibacterial antibiotic produced by Streptomyces flocculus . [1] It is an inhibitor of nitric oxide-dependent activation of soluble guanylyl cyclase. [2]
The first total synthesis of streptonigrin was published in 1980, [3] a different total synthesis with significantly higher yield was reported in 2011. [4]